Skip to main content
NIH funding notice RFA-DK-27-108

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

Open. Closes March 10, 2027.

Posted
June 4, 2026
Close date
March 10, 2027
Activity codes
U01
Institutes taking part
NIDDK, NHLBI

The notices it replaced

1 notice since 2023, oldest first, each with its awards since FY2014.

  1. Posted 2023RFA-DK-23-0216 awards
  2. Posted 2026RFA-DK-27-108This notice, open

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
6
6 new
Median first-year cost
$1,009,029
$5,797,072 in all
Institutions
6
6 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. BRIGHAM AND WOMEN'S HOSPITAL1
  2. JOSLIN DIABETES CENTER1
  3. UNIVERSITY OF CALIFORNIA, SAN DIEGO1
  4. UNIVERSITY OF VIRGINIA1
  5. UNIVERSITY OF WASHINGTON1

and 1 other institution

Most frequent study sections

  1. Special Emphasis Panel (ZDK1 GRB-T (O1))6
6 awards under RFA-DK-27-108 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2024Immunometabolism and the Cardio-Renal Axis in T1D-associated Atherosclerosis: Insights from the CaRe T1D Biobank1U01DK142249-01 · under RFA-DK-23-021Bjornstad, PetterBornfeldt, Karin E.Vaisar, TomasUNIVERSITY OF WASHINGTON, WAFirst-year cost $1,080,680Study section ZDK1
FY2024Discovery and therapeutic targeting non-coding RNAs in T1D- or T2D-associated atherosclerosis1U01DK142281-01 · under RFA-DK-23-021Feinberg, Mark WBRIGHAM AND WOMEN'S HOSPITAL, MAFirst-year cost $1,022,611Study section ZDK1
FY2024Characterization of risk factors for excessive cardiovascular diseases (CVD) from circulating and cardiovascular tissues of people with well-controlled chronic type 1 diabetes1U01DK142331-01 · under RFA-DK-23-021King, George LJOSLIN DIABETES CENTER, MAFirst-year cost $1,009,308Study section ZDK1
FY2024Single-cell, multi-omic investigation of epicardial adipose and coronary endothelial dysfunction in type 1 diabetes1U01DK142338-01 · under RFA-DK-23-021Gupta, Rajat MMajithia, AmitUNIVERSITY OF CALIFORNIA, SAN DIEGO, CAFirst-year cost $1,008,750Study section ZDK1
FY2024Molecular Drivers of Atherosclerosis in Diabetes1U01DK142283-01 · under RFA-DK-23-021Civelek, MeteMiller, Clint LOnengut, SunaUNIVERSITY OF VIRGINIA, VAFirst-year cost $962,975Study section ZDK1
FY2024Substance P Metabolites and Receptors in the Pathogenesis of Cardiac Disease in Type 1 Diabetes1U01DK142329-01 · under RFA-DK-23-021Campbell, William BrysonLevick, Scott PWEST VIRGINIA UNIVERSITY, WVFirst-year cost $712,748Study section ZDK1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.